In brief

BMJ 2005; 331 doi: (Published 08 September 2005) Cite this as: BMJ 2005;331:532

WHO says monitor resistance to new malaria drugs: Countries have been urged by the World Health Organization to monitor closely the effectiveness of artemisinin based combination therapies, the recommended treatment option for countries where resistance to standard malaria drugs is a problem. See

Neglected disease research threatened: Public-private partnerships have been a critical driver of research into …

View Full Text

Sign in

Log in through your institution